Novel method
AssigneeGammaDelta Therapeutics Ltd
InventorsAndrew John HUTTON, Istvan KOVACS, Oliver NUSSBAUMER
Life of this patent
Estimating the term…
Loading patent…
AssigneeGammaDelta Therapeutics Ltd
InventorsAndrew John HUTTON, Istvan KOVACS, Oliver NUSSBAUMER
Estimating the term…
The invention relates to methods for expanding γδ T cells comprising preparing a composition enriched for γδ T cells and culturing the composition in the presence of feeder cells. Also provided is a method for engineering γδ T cells comprising preparing a composition enriched for γδ T cells, transducing the composition to express a chimeric antigen receptor (CAR) specific for a tumour associated antigen and culturing the transduced composition to expand the engineered γδ T cells. Also provided are expanded and engineered γδ T cells produced according to the described methods, which find utility in adoptive T cell therapies, chimeric receptor therapies and the like.
A method for expanding γδ T cells, wherein said method comprises the steps of:
A method for expanding γδ T cells, wherein said method comprises the steps of:
A method for expanding γδ T cells, wherein said method comprises the steps of:
A method for engineering γδ T cells, said method comprising the steps of:
Dependencies are inferred from the claim text.